Core Scientific (NASDAQ:CORZ) Shares Climb 10.8% – Time to Buy?

Core Scientific, Inc. (NASDAQ:CORZ)’s stock price was up 10.8% during trading on Tuesday. The company traded as high as $13.86 and last traded at $13.8560. 8,925,532 shares were traded during mid-day trading, a decline of 30% from the average session volume of 12,774,271 shares. The stock had previously closed at $12.51.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: For the quarter ended September 2026, Core Scientific earned $0.47 per share, versus analysts’ expected loss, and generated $232.87 million in revenue, above the $196.36 million consensus. Earnings also improved from a loss of $0.46 per share a year earlier. Core Scientific surpasses Q3 earnings and revenue estimates
• Neutral Sentiment: Analyst views remain broadly favorable but varied: the average rating was “Moderate Buy,” with a reported average price target of $31.28, while individual firms’ ratings and targets ranged from bearish to bullish. MarketBeat Core Scientific coverage
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for about $127,800. The sale was a small reduction—0.88%—in his holdings, so it may weigh on sentiment but does not indicate a major change in his position. Core Scientific insider share sale

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on CORZ shares. Citigroup restated a “market outperform” rating on shares of Core Scientific in a research note on Wednesday, October 14th. Rothschild & Co Redburn initiated coverage on shares of Core Scientific in a research note on Monday, September 21st. They issued a “neutral” rating and a $16.00 target price on the stock. B. Riley Financial dropped their target price on shares of Core Scientific from $42.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, October 30th. Wolfe Research reissued a “buy” rating on shares of Core Scientific in a research report on Wednesday, July 29th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $39.00 target price on shares of Core Scientific in a research report on Wednesday, October 14th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $31.28.

Core Scientific Stock Performance

The company’s 50 day moving average is $15.80 and its 200 day moving average is $19.52.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.54. The company had revenue of $232.87 million during the quarter, compared to analyst estimates of $196.36 million. Equities analysts predict that Core Scientific, Inc. will post -1.36 earnings per share for the current year.

Insider Transactions at Core Scientific

In other news, Director Eric Weiss purchased 6,000 shares of the business’s stock in a transaction on Tuesday, September 15th. The stock was purchased at an average price of $16.33 per share, with a total value of $97,980.00. Following the acquisition, the director directly owned 265,262 shares in the company, valued at approximately $4,331,728.46. The trade was a 2.31% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Todd M. Duchene sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $12.78, for a total value of $127,800.00. Following the completion of the sale, the insider owned 1,123,286 shares of the company’s stock, valued at $14,355,595.08. This represents a 0.88% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have purchased 19,000 shares of company stock worth $342,290 and have sold 100,000 shares worth $1,628,600. 1.70% of the stock is owned by company insiders.

Institutional Trading of Core Scientific

A number of institutional investors and hedge funds have recently modified their holdings of CORZ. Parkside Financial Bank & Trust raised its stake in shares of Core Scientific by 1,371.3% in the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock valued at $30,000 after purchasing an additional 1,097 shares in the last quarter. CoreCap Advisors LLC acquired a new stake in Core Scientific during the second quarter worth $36,000. Parallel Advisors LLC boosted its stake in Core Scientific by 125.0% during the third quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock worth $29,000 after buying an additional 1,000 shares in the last quarter. Rakuten Securities Inc. bought a new stake in Core Scientific in the 2nd quarter valued at $47,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in Core Scientific in the 3rd quarter valued at $42,000.

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.